G. OʼConnell

Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group.

K. Swenerton, J Jeffrey, Gavin Stuart et al. · Journal of Clinical Oncology · 1992 · 214 citations

Predictive value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses.

G. OʼConnell, Eamonn D. Ryan, Kieran J. Murphy et al. · PubMed · 1987 · 85 citations

Surgical Oncology, Pelvic Reconstructive Surgery, Gynecology +21

Ovarian toxicity of cyclophosphamide alone and in combination with ovarian irradiation in the rat.

John Jarrell, Eleonora Lai, RM Barr et al. · PubMed · 1987 · 77 citations

Hormonal Contraceptive, Fertility, Local Irradiation +19

Two Phase I Studies of Carboplatin Dose Escalation in Chemotherapy-Naive Ovarian Cancer Patients Supported With Patients Supported With Granulocyte-Macrophage Colony-Stimulating Factor

James J. Rusthoven, Leslie Levin, E. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 1991 · 29 citations

A rapid and simple method for the purification of tumor cells from ascitic fluid of ovarian carcinoma

Hal W. Hirte, D.A. Clark, J. Mazurka et al. · Gynecologic Oncology · 1992 · 27 citations

Cell Culture, Tumor Cells, Cell Biology +9